We are live on ! Find out more
NERM

New England Research & Management Portfolio holdings

AUM $257M
1-Year Est. Return 25.66%
This Fund
S&P 500
This Quarter Est. Return
+10.74%
1 Year Est. Return
+25.66%
3 Year Est. Return
+56.38%
5 Year Est. Return
+58.71%
10 Year Est. Return
+176.32%
AUM
$189M
AUM Growth
+$13.3M
Cap. Flow
-$3.27M
Cap. Flow %
-1.73%
Top 10 Hldgs %
24.14%
Holding
169
New
20
Increased
29
Reduced
82
Closed
14

Top Buys

Rank Stock Value
1
J icon
Jacobs Solutions
J
+$3M
2
APD icon
Air Products & Chemicals
APD
+$2.21M
3
ORCL icon
Oracle
ORCL
+$1.67M
4
TER icon
Teradyne
TER
+$1.12M
5
PH icon
Parker-Hannifin
PH
+$953K

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$1.82M
2
AMZN icon
Amazon
AMZN
+$1.48M
3
AVGO icon
Broadcom
AVGO
+$1.19M
4
AMGN icon
Amgen
AMGN
+$1.13M
5
SBUX icon
Starbucks
SBUX
+$1.01M

Sector Composition

Rank Sector Weight
1 Industrials 21.74%
2 Healthcare 18.33%
3 Technology 16.98%
4 Consumer Staples 11.96%
5 Consumer Discretionary 9.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABT icon
26
Abbott
ABT
$177B
$2.04M 1.08%
18,574
-200
-1% -$20K
XOM icon
27
ExxonMobil
XOM
$696B
$1.98M 1.05%
19,761
TER icon
28
Teradyne
TER
$52B
$1.96M 1.04%
18,050
+11,850
+191% +$1.12M
SYY icon
29
Sysco
SYY
$38.1B
$1.93M 1.02%
26,334
-450
-2% -$31.1K
MS icon
30
Morgan Stanley
MS
$324B
$1.92M 1.01%
20,542
-875
-4% -$70K
UTHR icon
31
United Therapeutics
UTHR
$21.5B
$1.77M 0.94%
8,035
-470
-6% -$108K
YUM icon
32
Yum! Brands
YUM
$38.4B
$1.73M 0.92%
13,251
-199
-1% -$24.8K
H icon
33
Hyatt Hotels
H
$15.1B
$1.69M 0.89%
12,950
-3,550
-22% -$403K
PEP icon
34
PepsiCo
PEP
$185B
$1.68M 0.89%
9,893
-25
-0.3% -$4.15K
AMGN icon
35
Amgen
AMGN
$203B
$1.67M 0.89%
5,800
-4,160
-42% -$1.13M
MRK icon
36
Merck
MRK
$355B
$1.67M 0.89%
15,324
-600
-4% -$62.3K
ADI icon
37
Analog Devices
ADI
$175B
$1.64M 0.87%
8,250
-3,400
-29% -$607K
GOOG icon
38
Alphabet (Google) Class C
GOOG
$4.18T
$1.62M 0.86%
11,494
GEHC icon
39
GE HealthCare
GEHC
$28.9B
$1.6M 0.85%
20,653
-5,808
-22% -$407K
LLY icon
40
Eli Lilly
LLY
$1.01T
$1.59M 0.84%
2,735
+1,045
+62% +$610K
EL icon
41
Estee Lauder
EL
$34.8B
$1.56M 0.83%
10,650
-3,098
-23% -$411K
SPG icon
42
Simon Property Group
SPG
$66B
$1.5M 0.8%
10,525
-400
-4% -$48.4K
MDT icon
43
Medtronic
MDT
$120B
$1.49M 0.79%
18,034
-470
-3% -$35.8K
MDC
44
DELISTED
M.D.C. Holdings, Inc.
MDC
$1.44M 0.76%
26,021
-425
-2% -$18.8K
SYK icon
45
Stryker
SYK
$108B
$1.4M 0.74%
4,685
+1,585
+51% +$445K
DIS icon
46
Walt Disney
DIS
$184B
$1.38M 0.73%
15,302
-260
-2% -$22.9K
PG icon
47
Procter & Gamble
PG
$341B
$1.35M 0.72%
9,246
AMZN icon
48
Amazon
AMZN
$2.68T
$1.35M 0.72%
8,888
-10,545
-54% -$1.48M
IBM icon
49
IBM
IBM
$234B
$1.33M 0.7%
8,119
-2,655
-25% -$401K
TGT icon
50
Target
TGT
$70.1B
$1.32M 0.7%
9,275
-3,325
-26% -$406K

Similar funds

New England Research & Management's Q4 2023 Portfolio in Review

As of Q4 2023, New England Research & Management held 169 positions worth $189M, up 7.6% from $175M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

New England Research & Management's Q4 2023 filing shows 20 new, 29 increased, 82 reduced and 14 closed positions. Its largest new stake was Jacobs Solutions: 27,534 shares worth $2.96M. The largest sale was UnitedHealth, an estimated $1.82M.

By sector, the portfolio is most concentrated in Industrials at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Technology.

  • New England Research & Management's largest Q4 2023 buy was Jacobs Solutions: 27,534 shares worth $2.96M.
  • New England Research & Management added most to Oracle in Q4 2023, an estimated $1.67M increase.
  • New England Research & Management's biggest Q4 2023 reduction was UnitedHealth, cutting an estimated $1.82M.
  • New England Research & Management fully exited Broadcom in Q4 2023, selling an estimated $1.19M.
  • New England Research & Management's ten largest holdings make up 24% of its $189M portfolio in Q4 2023.
  • New England Research & Management opened 20 new positions and closed 14 in Q4 2023.
  • New England Research & Management's portfolio value rose 7.6% quarter-over-quarter to $189M.

Based on New England Research & Management's 13F filing for Q4 2023, filed 6 Feb 2024.